EQL Pharma AB
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2018-11-16 | EQL Pharma AB | Alexander Brising | Business Development Director | Subscription | 383 | 6 | SEK | 2 298 | 2018-11-12 |
| 2018-11-16 | EQL Pharma AB | Alexander Brising | Business Development Director | Exercise decrease | 2 300 | 0 | SEK | 0 | 2018-11-12 |
| 2018-11-16 | EQL Pharma AB | Alexander Brising | Business Development Director | Subscription | 383 | 6 | SEK | 2 298 | 2018-11-12 |
| 2018-11-16 | EQL Pharma AB | Alexander Brising | Business Development Director | Exercise decrease | 2 300 | 0 | SEK | 0 | 2018-11-12 |
| 2018-11-16 | EQL Pharma AB | Alexander Brising | Business Development Director | Subscription | 383 | 6 | SEK | 2 298 | 2018-11-12 |
| 2018-11-16 | EQL Pharma AB | Alexander Brising | Business Development Director | Acquisition | 2 300 | 13 | SEK | 29 900 | 2017-09-21 |
| 2018-11-16 | EQL Pharma AB | Alexander Brising | Business Development Director | Acquisition | 2 300 | 13 | SEK | 29 900 | 2017-09-21 |
| 2018-11-16 | EQL Pharma AB | Alexander Brising | Business Development Director | Acquisition | 2 300 | 13 | SEK | 29 900 | 2017-09-21 |
| 2018-11-16 | EQL Pharma AB | Catarina Hjelm | Regulatory Affairs manager | Exercise decrease | 9 996 | 0 | SEK | 0 | 2018-11-12 |
| 2018-11-16 | EQL Pharma AB | Catarina Hjelm | Regulatory Affairs manager | Subscription | 1 666 | 6 | SEK | 9 996 | 2018-11-12 |
| 2018-11-16 | EQL Pharma AB | Rajiv I Modi | Styrelseledamot | Subscription | 1 245 500 | 6 | SEK | 7 473 000 | 2018-11-12 |
| 2018-11-16 | EQL Pharma AB | Rajiv I Modi | Styrelseledamot | Exercise decrease | 7 473 000 | 0 | SEK | 0 | 2018-11-12 |
| 2018-11-16 | EQL Pharma AB | Alexander Brising | Business Development Director | Acquisition | 38 622 | 0,61 | SEK | 23 559,42 | 2018-10-29 |
| 2018-11-15 | EQL Pharma AB | Lars Holmqvist | Styrelseledamot/suppleant | Acquisition | 243 232 | 0 | SEK | 0 | 2018-11-06 |
| 2018-11-15 | EQL Pharma AB | Lars Holmqvist | Styrelseledamot/suppleant | Disposal | 243 232 | 0 | SEK | 0 | 2018-11-06 |
| 2018-11-15 | EQL Pharma AB | Lars Holmqvist | Styrelseledamot/suppleant | Exercise decrease | 243 232 | 0 | SEK | 0 | 2018-11-12 |
| 2018-11-15 | EQL Pharma AB | Lars Holmqvist | Styrelseledamot/suppleant | Disposal | 4 | 0,45 | SEK | 1,8 | 2018-11-06 |
| 2018-11-15 | EQL Pharma AB | Lars Holmqvist | Styrelseledamot/suppleant | Subscription | 40 538 | 6 | SEK | 243 228 | 2018-11-12 |
| 2018-11-14 | EQL Pharma AB | Axel Schörling | Operativ chef, COO | Subscription | 13 286 | 6 | SEK | 79 716 | 2018-11-12 |
| 2018-11-14 | EQL Pharma AB | Axel Schörling | Operativ chef, COO | Exercise decrease | 79 716 | 0 | SEK | 0 | 2018-11-12 |